Recall Register

Food, drugs, devices › Medtronic Inc.

Device recall: Medtronic MiniMed 630G 6025805-003_C, Rx Only Medtronic MiniMed 670G 6025805-005_B, Rx Only Medtronic MiniMed 640G (Inte

FDA enforcement event 81246 · Class II · initiated 3 Oct 2018 · status Ongoing

DeviceVoluntary: Firm initiated1 product recordNorthridge, CA

Medtronic Inc. (Northridge, CA) initiated this device recall on 3 Oct 2018; FDA lists 1 product record under event 81246, classified Class II.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 92% of the 1,074 device enforcement events initiated in 2018 carry the same class.

Status: Ongoing. Initiation: voluntary: firm initiated. Medtronic Inc. has 47 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Medtronic Inc., Northridge, CA.

Reason for recall

"Reports of occurrences in which insulin pumps with version 4.10 software have failed to make expected audio sounds during alerts, alarms or sirens. This could cause a user to miss system notifications, alarms or sirens associated with how the pump is working, and with high and low glucose alerts."

Distribution

"US: AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, Puerto Rico, RI, VT, SC, SD, TN, TX,…"

Product records

Recall numberProductQuantityClassStatusReport date
Z-0683-2019Medtronic MiniMed 630G 6025805-003_C, Rx Only Medtronic MiniMed 670G 6025805-005_B, Rx Only Medtronic MiniMed 640G (International)142889Class IIOngoing2 Jan 2019

Context

92%of 2018 device events are Class II1,074 events that year
1product record in this eventfirm median: 1
47events on this register for the firm

Other enforcement events for Medtronic Inc.

InitiatedProduct (first record)TypeClassRecords
11 Mar 2026Medtronic Sphere-9 Catheter, Model Number AFR-00001; catheter, percutaneous, cardiac ablation, for treatment of atrial fDeviceClass II1
4 Dec 2025Abre Venous Self-Expanding Stent System, Model numbers AB9G14120090 AB9G12100090 AB9G14080090 AB9G12080090 AB9U12060090 DeviceClass II1
29 Oct 2025Aurora EV-ICD and Clinical EV-ICD, single chamber, extravascular implantable cardioverter defibrillators (ICD), Product DeviceClass II1
18 Jun 2025Medtronic CareLink SmartSync Patient Connector, Model Number 24967 with the following software components: 1. Cobalt CroDeviceClass II2
17 Jun 2025Medtronic SmartLink Software loaded on SmartSync Patient Connector, Model Number 24967 with the following software compoDeviceClass II2
29 Apr 2025Azure S DR MRI SureScan, Product number W3DR01DeviceClass II1
11 Jul 20242090 Programmers with serial number prefixes PKK0 and PKK1: a) 2090, Product Description: PRGM 2090 PROGRAMMER-PORTABLE DeviceClass II1
16 Apr 2024COBALT HF QUAD CRT-D MRI SureScan, Model Number DTPB2QQ, Implantable Cardioverter DefibrillatorDeviceClass II23
16 Feb 2024Abre Venous Self-expanding Stent System, Product Numbers: a) AB9U14080090; b) AB9U18100090; c) AB9G14100090DeviceClass II1
7 Dec 2023Cobalt XT DR MRI SureScan Implantable Cardioverter Defibrillator, product number DDPA2D1DeviceClass II1

All 47 events for Medtronic Inc.

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "Reports of occurrences in which insulin pumps with version 4.10 software have failed to make expected audio sounds during alerts, alarms or sirens. This could cause a user to miss system notifications, alarms or sirens associated with how the pump is working, and with high and low glucose alerts."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "US: AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, Puerto Rico, RI, VT, SC, SD, TN, TX,…"

Is the recall still ongoing?

FDA lists the status as Ongoing. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.